ArticleMolecular cancer2024

Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer.

Cheng-Ke Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.